# Intravenous rhTNK-tPA Before Stroke Thrombectomy in the Extended Time Window

> **NCT06987305** · PHASE3 · RECRUITING · sponsor: **Xinqiao Hospital of Chongqing** · enrollment: 820 (estimated)

## Conditions studied

- Stroke, Acute Ischemic

## Interventions

- **DRUG:** Intravenous rhTNK-tPA
- **DRUG:** Intravenous placebo
- **PROCEDURE:** Endovascular thrombectomy

## Key facts

- **NCT ID:** NCT06987305
- **Lead sponsor:** Xinqiao Hospital of Chongqing
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-21
- **Primary completion:** 2027-10-31
- **Final completion:** 2028-02-29
- **Target enrollment:** 820 (ESTIMATED)
- **Last updated:** 2025-12-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06987305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06987305, "Intravenous rhTNK-tPA Before Stroke Thrombectomy in the Extended Time Window". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06987305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*